Journal Logo

March 2020 - Volume 31 - Issue 3
pp: 205-318


Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Grenader, Tal; Pavel, Marianne E.; Ruszniewski, Philippe B.; More

Anti-Cancer Drugs. 31(3):216-222, March 2020.

Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest

Yamashita, Takuma; Kato, Kiyohito; Fujihara, Shintaro; More

Anti-Cancer Drugs. 31(3):231-240, March 2020.

Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models

Shu, Sei; Yamashita-Kashima, Yoriko; Yanagisawa, Mieko; More

Anti-Cancer Drugs. 31(3):241-250, March 2020.

Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells

Cabral-Romero, Claudio; Solís-Soto, Juan M.; Sánchez-Pérez, Yesennia; More

Anti-Cancer Drugs. 31(3):251-259, March 2020.


Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer

Petrioli, Roberto; Francini, Edoardo; Cherri, Sara; More

Anti-Cancer Drugs. 31(3):292-297, March 2020.

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study

Shiota, Masaki; Nakamura, Motonobu; Yokomizo, Akira; More

Anti-Cancer Drugs. 31(3):298-303, March 2020.